Literature DB >> 29168343

Lipocalin 2 (Lcn2) interferes with iron uptake by Brucella abortus and dampens immunoregulation during infection of RAW 264.7 macrophages.

Huynh Tan Hop1, Lauren Togonon Arayan1, Tran Xuan Ngoc Huy1, Alisha Wehdnesday Bernardo Reyes1, Eun Jin Baek1, Wongi Min1, Hu Jang Lee1, Man Hee Rhee2, Kenta Watanabe3, Hong Hee Chang4, Suk Kim1,4.   

Abstract

Lipocalin 2 (Lcn2) is an important innate immunity component against bacterial pathogens. In this study, we report that Lcn2 is induced by Brucella (B.) abortus infection and significantly contributes to the restriction of intracellular survival of Brucella in macrophages. We found that Lcn2 prevented iron uptake by B. abortus through two distinct mechanisms. First, Lcn2 is secreted to capture bacterial siderophore(s) and abrogate iron import by Brucella. Second, Lcn2 decreases the intracellular iron levels during Brucella infection, which probably deprives the invading Brucella of the iron source needed for growth. Suppression of Lcn2 signalling resulted in a marked induction of anti-inflammatory cytokine, interleukin 10, which was shown to play a major role in Lcn2-induced antibrucella immunity. Similarly, interleukin 6 was also found to be increased when Lcn2 signalling is abrogated; however, this induction was thought to be an alternative pathway that rescues the cell from infection when the effective Lnc2 pathway is repressed. Furthermore, Lcn2 deficiency also caused a marked decrease in brucellacidal effectors, such as reactive oxygen species and nitric oxide but not the phagolysosome fusion. Taken together, our results indicate that Lcn2 is required for the efficient restriction of intracellular B. abortus growth that is through limiting iron acquisition and shifting cells to pro-inflammatory brucellacidal activity in murine macrophages.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  Brucella abortus; NO; ROS; apoptosis; iron sequestrating; lipocalin 2

Mesh:

Substances:

Year:  2017        PMID: 29168343     DOI: 10.1111/cmi.12813

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  6 in total

1.  Integrated Bioinformatics Analysis for the Identification of Key Molecules and Pathways in the Hippocampus of Rats After Traumatic Brain Injury.

Authors:  Xiao Xiao; Peng Bai; Shuqiang Cao; Youjing Jiang; Weibo Liang; Tao Wang; Xiaolei Luo; Qiaozhi Guan; Linbo Gao; Lin Zhang
Journal:  Neurochem Res       Date:  2020-01-30       Impact factor: 3.996

2.  IRF3 inhibits IFN-γ-mediated restriction of intracellular pathogens in macrophages independently of IFNAR.

Authors:  Karolina Maciag; Raktima Raychowdhury; Karen Smith; Alexis M Schneider; Jörn Coers; Maxwell R Mumbach; Schraga Schwartz; Nir Hacohen
Journal:  J Leukoc Biol       Date:  2021-11-26       Impact factor: 6.011

3.  Herb Formula (GCis) Prevents Pulmonary Infection Secondary to Intracerebral Hemorrhage by Enhancing Peripheral Immunity and Intestinal Mucosal Immune Barrier.

Authors:  Yulu Miao; Bin Wang; Jing Hu; Hanyu Zhang; Xiaojin Li; Yingying Huang; Pengwei Zhuang; Yanjun Zhang
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

4.  Lipocalin 2 links inflammation and ankylosis in the clinical overlap of inflammatory bowel disease (IBD) and ankylosing spondylitis (AS).

Authors:  Aifeng Lin; Robert D Inman; Catherine J Streutker; Zhenbo Zhang; Kenneth P H Pritzker; Hing Wo Tsui; Florence W L Tsui
Journal:  Arthritis Res Ther       Date:  2020-03-18       Impact factor: 5.156

5.  Lipocalin 2 Protects Against Escherichia coli Infection by Modulating Neutrophil and Macrophage Function.

Authors:  Qianqian Wang; Shuhui Li; Xueyou Tang; Li Liang; Fengqin Wang; Huahua Du
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561

6.  TLR3 Deficiency Leads to a Dysregulation in the Global Gene-Expression Profile in Murine Oviduct Epithelial Cells Infected with Chlamydia muridarum.

Authors:  Ramesh Kumar; Wilbert A Derbigny
Journal:  Int J Microbiol Curr Res       Date:  2018-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.